ExQor Technologies, a biotech firm based in Boston, is moving into an important stage of its mission to fight Alzheimer’s disease with a new brain healing treatment. They are getting ready for clinical trials after strong results from early research that suggest a new way to treat brain diseases. Unlike current medicines that just slow down the loss of mental abilities, ExQor’s method aims to fix the damage and help the brain repair itself. They also have another study planned for frontotemporal dementia, with more plans to expand into other conditions that affect the mind.
Health Technology Insights: Sandoz Launches Affordable Iron Sucrose Injection in US
In early tests, the treatment showed good results in several models of diseases. These included not just Alzheimer’s, but also brain damage from HIV and long-term use of methamphetamine. In all these cases, the treatment stopped more brain cell loss, helped memory and learning, and protected the brain from more harm. These findings have been shared at big science meetings and published in respected journals, showing the strong data and the wide-ranging use of the treatment.
A big part of the success is the technology that can deliver medicine directly into the brain. Usually, the blood-brain barrier stops most drugs from reaching the brain effectively. ExQor’s system gets around this with a non-invasive method that allows more of the medicine to reach the brain. This makes treatment possible in outpatient clinics or even at home, making it easier for patients and possibly cheaper.
Health Technology Insights: PepGen Reports Top Splicing Correction in DM1 Patients
In animal tests, the therapy caused the growth of new brain cells, helped those cells stay alive, and improved how they talk to each other. These changes led to better memory and learning, with no side effects even at low doses. The treatment also kept protecting the brain over time, showing promise for long-term benefits.
ExQor is also developing new ways to find diseases like Alzheimer’s earlier using regular MRI scans. This could let doctors spot people at risk before symptoms get bad. The goal is to create a full system for managing disease, from early detection and continuous check-ups to easy and effective treatment. This could change how brain disorders are treated, making care more complete and affordable. The simple way it’s delivered and the chance for home use could make it widely available, especially where specialized care is hard to get. With dementia costs expected to rise to over $1.6 trillion globally by 2050, ExQor’s innovation could provide both medical and financial relief worldwide.
Health Technology Insights: FUJIFILM Biotech Opens New Cell Culture Manufacturing Site
To participate in our interviews, please write to our HealthTech Media Room at sudipto@intentamplify.com
